• Acino in Latin America
    • Company Profile
    • Our Culture
    • Our Management
    • Our History
  • Services
    • We Partner
    • We Market
  • Products
  • We Care
  • Media
  • Careers
  • Contact Us
Portuguese (Brazil)Spanish
  • Acino in Latin America
    • Company Profile
    • Our Culture
    • Our Management
    • Our History
  • Services
    • We Partner
    • We Market
  • Products
  • We Care
  • Media
  • Careers
  • Contact Us

We use cookies to create statistics that help us to improve the quality of our website and your user experience. By clicking on “Accept All”, you consent to the processing of data by Acino and the transfer of data to third parties. You can also tailor your consent for specific data processing purposes. Once you have made your choice, click on “Confirm”. Find detailed information and modify your preferences at any time in our Privacy Notice.

Necessary Cookies Always Active

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytics Cookies

We would like to set Google Analytics cookies to help us analyse the traffic on our website.

20.02.2026

Driving innovation, quality, and trust through digitalization in manufacturing

In partnership with IQVIA, we have successfully implemented a new electronic Quality Management System (eQMS) consisting of six SmartSolve modules across...

03.02.2026

Arcera Life Sciences Convenes Global Healthcare Leaders in Abu Dhabi to Accelerate AI-Powered Healthcare Transformation Across the Middle East and beyond

Held during the annual “UAE Innovates” month, which aims to reinforce the UAE’s position as an international beacon of innovation,...

31.01.2026

Arcera Life Sciences Drives Healthcare Innovation with Strategic ISPOR UAE Chapter Partnership and Novel Antibiotic Launch to Combat Antimicrobial Resistance in the UAE

Signed during the ISPOR UAE Chapter 2026 Conference in Abu Dhabi, the Memorandum of Understanding (MoU) coincides with the launch...

16.01.2026

Ariprazol® Receives Qualification Release in the EU and Launches Sales in Latvia

Acino, part of Arcera, has obtained a qualification release for its prescription antipsychotic medicine Ariprazol® (aripiprazole) in the European Union,...

16.01.2026

Acino South Africa certified as Top Employer

Acino South Africa has been certified as a Top Employer by the independent Top Employers Institute for the fifth consecutive...

18.12.2025

Arcera Life Sciences releases inaugural Sustainability Report

The 2024 report outlines Arcera’s current ESG initiatives and long-term ambitions, including a firm commitment to achieving full carbon neutrality...

21.11.2025

Acino Iraq Recognised as Best Place to Work

We are thrilled to announce that Acino, part of Arcera, has been certified as one of the Best Place to...

02.09.2025

Acino в Україні розширює портфель продуктами Klosterfrau Healthcare Group

Acino, part of Arcerа, уклала стратегічну дистриб’юторську угоду з німецькою фармацевтичною компанією Klosterfrau Healthcare Group щодо комерціалізації та промоції в Україні трьох...

10.06.2025

AriBio and Arcera Sign Exclusive Licensing and Supply Agreements for Investigational Drug for Alzheimer’s Disease

Seongnam-si, South Korea and Abu Dhabi, UAE – June 10, 2025 – AriBio Co., Ltd. (“AriBio”), a South Korean biopharmaceutical company...

Contact UsReport an Adverse Event
Acino - Part of Arcera
  • Acino in Latin America
  • Company Profile
  • Our Culture
  • Our Management
  • Our History
  • Services
  • We Partner
  • We Market
  • Products
  • We Care

  • Privacy
  • Terms of Use
  • Social Media Community Guidelines
Back to top

© 2026 Acino Latinoamericana S.A.

This site is intended for audiences in Latin America and provides general information about our products to a wide range of consumers. Some content may not be available or applicable in your country. Please note that we are not responsible for your access to such content. For country-specific information, we recommend consulting your local regulatory authorities. For medical advice, always seek guidance from a qualified healthcare professional.